Ureaplasma urealyticum

The Ureaplasma urealyticum test detects the presence of Ureaplasma urealyticum, a small bacterium of the genital tract that can be associated with non-gonococcal urethritis, abnormal vaginal discharge, and complications in pregnancy. Modern testing typically uses nucleic acid amplification (NAAT/PCR) on first-catch urine or genital swabs to identify bacterial DNA with high sensitivity and specificity. Accurate identification helps distinguish colonisation from active infection and guides appropriate clinical management.

This home collection service provides discreet sample pickup and confidential testing at Dubai/UAE-certified laboratories, with results and clinical guidance returned to you securely. Testing is useful for symptomatic individuals (dysuria, abnormal discharge), people with recurrent lower urinary tract symptoms, couples undergoing fertility assessment, and pregnant patients with risk factors; results can inform targeted antibiotic therapy or further culture for susceptibility if needed.

Samples accepted commonly include first‑catch urine or clinician‑guided self-collected vaginal/cervical/urethral swabs depending on sex and symptoms. Turnaround and reporting vary by lab but are typically within 24–72 hours; note that Ureaplasma can be a commensal organism, so clinical correlation is essential—do not self-medicate based solely on results, and consult a UAE‑licensed clinician for treatment, partner notification, and follow-up testing where appropriate.

• Ureaplasma urealyticum (NAAT/PCR)
• Quantitative Ureaplasma load (copies/mL)
• Co-detection of Mycoplasma hominis (when applicable)
• Antibiotic susceptibility (culture-based, if requested)

• Persistent or recurrent urethral/vaginal discharge
• Painful or burning urination (dysuria)
• Before or during fertility evaluation or assisted reproduction
• Pregnancy with symptoms or previous adverse pregnancy outcomes
• After unprotected sexual exposure to a partner with STI symptoms

• Discreet at‑home sample collection and pickup
• Testing in Dubai/UAE‑certified laboratories
• High-sensitivity NAAT results to aid diagnosis
• Fast clinical guidance from UAE‑licensed clinicians
• Confidential reporting and partner notification support

• First-catch urine (first 10–20 mL) or self-collected genital swab as instructed
• Avoid sexual intercourse 24 hours prior to sampling
• Do not douche or use vaginal products 48 hours before a swab
• Avoid antibiotics for at least 2 weeks prior, if clinically safe and advised